{"owner": "ArrayExpress Uploader", "pop_total": 0, "species": "human", "factors": [{"GSE14842GSM371301": {}}, {"GSE14842GSM371302": {}}, {"GSE14842GSM371303": {}}, {"GSE14842GSM371304": {}}, {"GSE14842GSM371305": {}}, {"GSE14842GSM371310": {}}, {"GSE14842GSM371311": {}}, {"GSE14842GSM371312": {}}, {"GSE14842GSM371313": {}}, {"GSE14842GSM371314": {}}, {"GSE14842GSM371315": {}}, {"GSE14842GSM371316": {}}, {"GSE14842GSM371317": {}}, {"GSE14842GSM371318": {}}], "id": 3169, "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "Increased numbers of mast cells and their products have been linked to symptom onset and severity in patients with chronic diarrhea and...", "geo_gse_id": "E-GEOD-14842", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 0, "sample_count": 14, "tags": ["cell", "diarrhea", "genome", "irritable bowel syndrome", "syndrome"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_id_plat": "E-GEOD-14842_A-AFFY-44", "slug": "transcription-profiling-of-human-ibs-patients-befo", "geo_gds_id": "", "name": "Transcription profiling of human IBS patients before and after treatment", "created": "Sep.12, 2014", "summary": "Increased numbers of mast cells and their products have been linked to symptom onset and severity in patients with chronic diarrhea and abdominal pain.  Although mast-cell inhibition ameliorates clinical manifestations and reduces mucosal inflammation, underlying molecular mechanisms remain unknown. Experiment Overall Design: Diarrhea-irritable bowel syndrome (d-IBS) patients were studied at baseline, or 6 months after natural evolution (control) or oral cromoglycate treatment. Jejunal biopsies were subjected to chip analysis (Affymetrix Human Genome U133 Plus 2.0 GeneChips).", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-14842", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-14842/samples/"}